Shared blood transcriptomic signatures between alzheimer’s disease and diabetes mellitus†

26Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

Abstract

Alzheimer’s disease (AD) and diabetes mellitus (DM) are known to have a shared molecular mechanism. We aimed to identify shared blood transcriptomic signatures between AD and DM. Blood expression datasets for each disease were combined and a co-expression network was used to construct modules consisting of genes with similar expression patterns. For each module, a gene regulatory network based on gene expression and protein-protein interactions was established to identify hub genes. We selected one module, where COPS4, PSMA6, GTF2B, GTF2F2, and SSB were identified as dysregulated transcription factors that were common between AD and DM. These five genes were also differentially co-expressed in disease-related tissues, such as the brain in AD and the pancreas in DM. Our study identified gene modules that were dysregulated in both AD and DM blood samples, which may contribute to reveal common pathophysiology between two diseases.

Cite

CITATION STYLE

APA

Lee, T., & Lee, H. (2021). Shared blood transcriptomic signatures between alzheimer’s disease and diabetes mellitus†. Biomedicines, 9(1), 1–16. https://doi.org/10.3390/biomedicines9010034

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free